Howard C. Dittrich works in Heart Failure & Transplant affiliated with Xylem (United States).
Howard C. Dittrich is a cardiologist serving as interim CEO at XyloCor Therapeutics. He is an adjunct professor of medicine and chair of the board of directors of the François M. Abboud Cardiovascular Research Center at the University of Iowa Carver College of Medicine. He previously held faculty positions at the University of California San Diego and leadership roles in biopharmaceutical companies focused on cardiovascular therapies.
210 pubs · 9,606 cites · h-index 50
MD
University of Iowa
1978
BS
University of Iowa
1975
XyloCor Therapeutics
2026 - Present
NovaCardia, Inc.
2001 - 2007